Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis

Theodora C. van Tilborg*, Simone C. Oudshoorn, Marinus J. C. Eijkemans, Monique H. Mochtar, Ron J. T. van Golde, Annemieke Hoek, Walter K. H. Kuchenbecker, Kathrin Fleischer, Jan Peter de Bruin, Henk Groen, Madelon van Wely, Cornelis B. Lambalk, Joop S. E. Laven, Ben Willem J. Mol, Frank J. M. Broekmans, Helen L. Torrance, OPTIMIST study Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2485-2495
Number of pages11
JournalHuman Reproduction
Volume32
Issue number12
DOIs
Publication statusPublished - Dec 2017

Keywords

  • antral follicle count
  • anti-Mullerian hormone
  • ovarian reserve
  • ovarian reserve test
  • IVF
  • ICSI
  • individualized
  • FSH
  • live birth
  • cost-effectiveness
  • IN-VITRO FERTILIZATION
  • ANTRAL FOLLICLE COUNT
  • RANDOMIZED CONTROLLED-TRIAL
  • ANTI-MULLERIAN HORMONE
  • PITUITARY DOWN-REGULATION
  • LIVE BIRTH-RATES
  • POOR RESPONDERS
  • IVF TREATMENT
  • PATIENT CHARACTERISTICS
  • ANTIMULLERIAN HORMONE

Cite this

van Tilborg, T. C., Oudshoorn, S. C., Eijkemans, M. J. C., Mochtar, M. H., van Golde, R. J. T., Hoek, A., Kuchenbecker, W. K. H., Fleischer, K., de Bruin, J. P., Groen, H., van Wely, M., Lambalk, C. B., Laven, J. S. E., Mol, B. W. J., Broekmans, F. J. M., Torrance, H. L., & OPTIMIST study Grp (2017). Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis. Human Reproduction, 32(12), 2485-2495. https://doi.org/10.1093/humrep/dex321